Uso de whey protein para tratar disbiose de ratos wistar com sintomas de autismo induzidos por ácido valproico

Detalhes bibliográficos
Autor(a) principal: Vasconcelos, Quezia Damaris Jones Severino
Data de Publicação: 2022
Tipo de documento: Dissertação
Idioma: por
Título da fonte: Repositório Institucional da Universidade Federal do Ceará (UFC)
Texto Completo: http://www.repositorio.ufc.br/handle/riufc/65930
Resumo: A great number of children with autism spectrum disorder (ASD) have a disproportionate gut microbiota composition which may worsen behavioral outcomes. Whey protein supplementation is associated with gut barrier regeneration and microbiota recovery, which might interfere in the neurodevelopment. Valproic acid (VPA) is a teratogenic drug capable of promoting 'autistic' features and dysbiosis. Therefore, the present study aims to evaluate the benefits of whey protein supplementation (1.24 mg/g - 24 days) in rats treated with VPA (400 mg/kg - single dose) regarding behavioral outcomes and dysbiosis. Young Wistar rats 14 days old were used (42 males and 35 females) and divided into four groups: control, ASD, whey protein with ASD and whey protein. At the end of the treatment, the pups were evaluated in the open field, social interaction, Y-maze, and marble burying tests, subsequently, the blood and the large intestine containing faeces were collected for analysis. Euthanasia was performed by anesthesia followed by exsanguination. The results showed that protein supplementation did not reverse weight loss, the decrease of plasma proteins, uric acid, HDL- c, and indirect bilirubin, along with blood alterations caused by VPA (p > 0.05). However, the supplement increased bacteria diversity and number of colonies in the animals’ faeces (p < 0.05), it also influenced microbiota composition, since bacteria from the Firmicutes phylum were found, predominantly, in the supplemented groups. In addition, improved the animal’s memory, as increased the percentage of arms alternation and decreased the return to the same arm, male and female, respectively. Whey protein was also able to decrease the time that the animal spent in the ‘alone chamber’, partially improving sociability (p < 0.05). Thus, whey protein treatment (1.24 mg/g - 24 days) positively influenced the gut microbiota, along with the animal’s sociability and memory.
id UFC-7_d5a8b08c03c7c6c6e7d9676c4c0dd9a8
oai_identifier_str oai:repositorio.ufc.br:riufc/65930
network_acronym_str UFC-7
network_name_str Repositório Institucional da Universidade Federal do Ceará (UFC)
repository_id_str
spelling Uso de whey protein para tratar disbiose de ratos wistar com sintomas de autismo induzidos por ácido valproicoProteínas do Soro do LeiteDisbioseÁcido ValproicoEutanásiaAutismoA great number of children with autism spectrum disorder (ASD) have a disproportionate gut microbiota composition which may worsen behavioral outcomes. Whey protein supplementation is associated with gut barrier regeneration and microbiota recovery, which might interfere in the neurodevelopment. Valproic acid (VPA) is a teratogenic drug capable of promoting 'autistic' features and dysbiosis. Therefore, the present study aims to evaluate the benefits of whey protein supplementation (1.24 mg/g - 24 days) in rats treated with VPA (400 mg/kg - single dose) regarding behavioral outcomes and dysbiosis. Young Wistar rats 14 days old were used (42 males and 35 females) and divided into four groups: control, ASD, whey protein with ASD and whey protein. At the end of the treatment, the pups were evaluated in the open field, social interaction, Y-maze, and marble burying tests, subsequently, the blood and the large intestine containing faeces were collected for analysis. Euthanasia was performed by anesthesia followed by exsanguination. The results showed that protein supplementation did not reverse weight loss, the decrease of plasma proteins, uric acid, HDL- c, and indirect bilirubin, along with blood alterations caused by VPA (p > 0.05). However, the supplement increased bacteria diversity and number of colonies in the animals’ faeces (p < 0.05), it also influenced microbiota composition, since bacteria from the Firmicutes phylum were found, predominantly, in the supplemented groups. In addition, improved the animal’s memory, as increased the percentage of arms alternation and decreased the return to the same arm, male and female, respectively. Whey protein was also able to decrease the time that the animal spent in the ‘alone chamber’, partially improving sociability (p < 0.05). Thus, whey protein treatment (1.24 mg/g - 24 days) positively influenced the gut microbiota, along with the animal’s sociability and memory.Uma grande parte das crianças com o transtorno do espectro autista (TEA) apresentam um desequilíbrio na composição da microbiota intestinal que pode agravar sintomas comportamentais. O uso da proteína do soro do leite (whey protein) está associada a regeneração da barreira intestinal e recuperação da microbiota, podendo influenciar no neurodesenvolvimento. O ácido valproico (VPA) é uma droga teratogênica capaz de induzir características ‘autísticas’ e disbiose. Portanto, o presente estudo tem por finalidade avaliar a suplementação de whey protein (1,24 mg/g - 24 dias) na disbiose intestinal e padrões comportamentais em ratos tratados com VPA (400 mg/kg - dose única). Foram usados ratos Wistar jovens com 14 dias de nascimento (42 machos e 35 fêmeas) sendo divididos nos seguintes grupos: controle, TEA, whey protein com TEA e whey protein. Ao término do tratamento os animais foram submetidos aos testes de campo aberto, interação social, Y-maze e marble burying, posteriormente, o sangue e intestino grosso contendo as fezes foram retirados para análises. A eutanásia foi feita por anestesia seguida de exsanguinação. Os resultados demonstraram que a suplementação proteica não foi capaz de reverter a perda de peso, diminuição de proteínas plasmáticas, ácido úrico, HDL-c, bilirrubina indireta e alterações hematológicas provocadas pelo VPA (p > 0,05). Entretanto, o suplemento aumentou a quantidade de colônias e diversidade bacteriana encontrada nos animais (p < 0,05), e também influenciou na composição da microbiota, com predomínio de bactérias do filo Firmicutes nos grupos suplementados. Além disso, melhorou a memória dos animais, pois aumentou a porcentagem alternância entre os braços e diminuiu o retorno ao braço, macho e fêmea, respectivamente. O whey protein também foi capaz de atenuar o tempo que o animal passou na câmera sozinho, melhorando, em parte, a sociabilidade (p < 0,05). Desse modo, o tratamento com whey protein (1,24 mg/g - 24 dias) teve influência positiva na microbiota intestinal, além de melhorar a sociabilidade e memória dos animais.Aragão, Gislei FrotaFrederico, Marisa Jadna SilvaVasconcelos, Quezia Damaris Jones Severino2022-05-18T15:57:46Z2022-05-18T15:57:46Z2022info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfVASCONCELOS, Q. D. J. R. Uso de whey protein para tratar disbiose de ratos wistar com sintomas de autismo induzidos por ácido valproico. 2022. 72 f. Dissertação (Mestrado Profissional em Farmacologia Clínica) - Faculdade de Medicina, Universidade Federal do Ceará, Fortaleza, 2022. Disponível em: http://www.repositorio.ufc.br/handle/riufc/65930. Acesso em: 18/05/2022.http://www.repositorio.ufc.br/handle/riufc/65930porreponame:Repositório Institucional da Universidade Federal do Ceará (UFC)instname:Universidade Federal do Ceará (UFC)instacron:UFCinfo:eu-repo/semantics/openAccess2022-05-19T13:12:35Zoai:repositorio.ufc.br:riufc/65930Repositório InstitucionalPUBhttp://www.repositorio.ufc.br/ri-oai/requestbu@ufc.br || repositorio@ufc.bropendoar:2024-09-11T18:32:59.071006Repositório Institucional da Universidade Federal do Ceará (UFC) - Universidade Federal do Ceará (UFC)false
dc.title.none.fl_str_mv Uso de whey protein para tratar disbiose de ratos wistar com sintomas de autismo induzidos por ácido valproico
title Uso de whey protein para tratar disbiose de ratos wistar com sintomas de autismo induzidos por ácido valproico
spellingShingle Uso de whey protein para tratar disbiose de ratos wistar com sintomas de autismo induzidos por ácido valproico
Vasconcelos, Quezia Damaris Jones Severino
Proteínas do Soro do Leite
Disbiose
Ácido Valproico
Eutanásia
Autismo
title_short Uso de whey protein para tratar disbiose de ratos wistar com sintomas de autismo induzidos por ácido valproico
title_full Uso de whey protein para tratar disbiose de ratos wistar com sintomas de autismo induzidos por ácido valproico
title_fullStr Uso de whey protein para tratar disbiose de ratos wistar com sintomas de autismo induzidos por ácido valproico
title_full_unstemmed Uso de whey protein para tratar disbiose de ratos wistar com sintomas de autismo induzidos por ácido valproico
title_sort Uso de whey protein para tratar disbiose de ratos wistar com sintomas de autismo induzidos por ácido valproico
author Vasconcelos, Quezia Damaris Jones Severino
author_facet Vasconcelos, Quezia Damaris Jones Severino
author_role author
dc.contributor.none.fl_str_mv Aragão, Gislei Frota
Frederico, Marisa Jadna Silva
dc.contributor.author.fl_str_mv Vasconcelos, Quezia Damaris Jones Severino
dc.subject.por.fl_str_mv Proteínas do Soro do Leite
Disbiose
Ácido Valproico
Eutanásia
Autismo
topic Proteínas do Soro do Leite
Disbiose
Ácido Valproico
Eutanásia
Autismo
description A great number of children with autism spectrum disorder (ASD) have a disproportionate gut microbiota composition which may worsen behavioral outcomes. Whey protein supplementation is associated with gut barrier regeneration and microbiota recovery, which might interfere in the neurodevelopment. Valproic acid (VPA) is a teratogenic drug capable of promoting 'autistic' features and dysbiosis. Therefore, the present study aims to evaluate the benefits of whey protein supplementation (1.24 mg/g - 24 days) in rats treated with VPA (400 mg/kg - single dose) regarding behavioral outcomes and dysbiosis. Young Wistar rats 14 days old were used (42 males and 35 females) and divided into four groups: control, ASD, whey protein with ASD and whey protein. At the end of the treatment, the pups were evaluated in the open field, social interaction, Y-maze, and marble burying tests, subsequently, the blood and the large intestine containing faeces were collected for analysis. Euthanasia was performed by anesthesia followed by exsanguination. The results showed that protein supplementation did not reverse weight loss, the decrease of plasma proteins, uric acid, HDL- c, and indirect bilirubin, along with blood alterations caused by VPA (p > 0.05). However, the supplement increased bacteria diversity and number of colonies in the animals’ faeces (p < 0.05), it also influenced microbiota composition, since bacteria from the Firmicutes phylum were found, predominantly, in the supplemented groups. In addition, improved the animal’s memory, as increased the percentage of arms alternation and decreased the return to the same arm, male and female, respectively. Whey protein was also able to decrease the time that the animal spent in the ‘alone chamber’, partially improving sociability (p < 0.05). Thus, whey protein treatment (1.24 mg/g - 24 days) positively influenced the gut microbiota, along with the animal’s sociability and memory.
publishDate 2022
dc.date.none.fl_str_mv 2022-05-18T15:57:46Z
2022-05-18T15:57:46Z
2022
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv VASCONCELOS, Q. D. J. R. Uso de whey protein para tratar disbiose de ratos wistar com sintomas de autismo induzidos por ácido valproico. 2022. 72 f. Dissertação (Mestrado Profissional em Farmacologia Clínica) - Faculdade de Medicina, Universidade Federal do Ceará, Fortaleza, 2022. Disponível em: http://www.repositorio.ufc.br/handle/riufc/65930. Acesso em: 18/05/2022.
http://www.repositorio.ufc.br/handle/riufc/65930
identifier_str_mv VASCONCELOS, Q. D. J. R. Uso de whey protein para tratar disbiose de ratos wistar com sintomas de autismo induzidos por ácido valproico. 2022. 72 f. Dissertação (Mestrado Profissional em Farmacologia Clínica) - Faculdade de Medicina, Universidade Federal do Ceará, Fortaleza, 2022. Disponível em: http://www.repositorio.ufc.br/handle/riufc/65930. Acesso em: 18/05/2022.
url http://www.repositorio.ufc.br/handle/riufc/65930
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Institucional da Universidade Federal do Ceará (UFC)
instname:Universidade Federal do Ceará (UFC)
instacron:UFC
instname_str Universidade Federal do Ceará (UFC)
instacron_str UFC
institution UFC
reponame_str Repositório Institucional da Universidade Federal do Ceará (UFC)
collection Repositório Institucional da Universidade Federal do Ceará (UFC)
repository.name.fl_str_mv Repositório Institucional da Universidade Federal do Ceará (UFC) - Universidade Federal do Ceará (UFC)
repository.mail.fl_str_mv bu@ufc.br || repositorio@ufc.br
_version_ 1813028850708250624